- Home
- DHT vs TVTX Comparison
DHT vs TVTX Comparison
Compare DHT & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DHT | TVTX |
|---|---|---|
| Founded | 2005 | N/A |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.3B |
| IPO Year | 2005 | 2013 |
Fundamental Metrics
Financial Performance| Metric | DHT | TVTX |
|---|---|---|
| Price | $18.63 | $30.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 14 |
| Target Price | $16.33 | ★ $36.62 |
| AVG Volume (30 Days) | ★ 5.2M | 1.1M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.41% | N/A |
| EPS Growth | N/A | ★ 92.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.85 | $44.62 |
| Revenue Next Year | N/A | $31.76 |
| P/E Ratio | $12.73 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.00 | $12.91 |
| 52 Week High | $20.55 | $42.13 |
Technical Indicators
Market Signals| Indicator | DHT | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 58.57 |
| Support Level | $10.85 | $26.53 |
| Resistance Level | $20.55 | $31.47 |
| Average True Range (ATR) | 0.70 | 1.19 |
| MACD | -0.02 | 0.50 |
| Stochastic Oscillator | 96.91 | 79.86 |
Price Performance
Historical ComparisonAbout DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.